Non Traumatic Acute Brain InjuryATLANREANCT02714387
Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study
An observational study of Non Traumatic Acute Brain Injury, run by Nantes University Hospital at 6 sites in France.
Trial summary
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions. Read more about this study
- Who is it for?
- Ages 15 years and older
- Conditions the study is for
- Non Traumatic Acute Brain Injury
- What is being tested?
- Collection of medical data
- How many people
- 5,000 participants
- Where
- 6 sitesFrance
- Study dates
- Feb 2013to Jan 2050
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Patients hospitalized in ICU for Non Traumatic Neuro-Vascular Diseases
Who may be able to join
- Non Traumatic Neuro-Vascular Diseases
Who cannot join
- Consent withdrawal
Trial locations and contacts
6 sites in 1 country. Contact the study team or a site near you to ask about taking part.
6 sites in 1 country
France6 sites, 6 recruiting
- Recruiting
Angers University Hospital
Angers, 49000
Sigismond Lasocki, PhD, MD, sigismond@lasocki.com
Sigismond Lasocki, PhD, MD
- Recruiting
CHU de Brest La Cavale Blanche
Brest, 29000
Olivier Huet, MD, PhD, olivier.huet@chu-brest.fr
Olivier Huet, MD, PhD
- Recruiting
Nantes University Hospital
Nantes, 44093
Karim Asehnoune, PhD, MD, 02 40 08 73 80 ext. 33, karim.asehnoune@chu-nantes.fr
Antoine Roquilly, MD, 02 40 08 73 80 ext. 33, antoine.roquilly@chu-nantes.fr
- Recruiting
Poitiers University Hospital
Poitiers, 86000
Olivier Mimoz, PhD, MD, o.mimoz@chu-poitiers.fr
Claire Dahyot, MD, claire.dahyot@chu-poitiers.fr
- Recruiting
Rennes University Hospital
Rennes, 35000
Yannick Malledant, PhD, MD, yannick.malledant@chu-rennes.fr
Philippe Seguin, PhD, MD, philippe.seguin@chu-rennes.fr
- Recruiting
Tours University Hospital
Tours, 37000
Martine Ferrandière, MD, ferrandiere@med.univ-tours.fr
Martine Ferrandière, MD
About this study
Official title: Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.
Read the detailed description
Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.
- Conditions
- Non Traumatic Acute Brain Injury
- Being tested
- Collection of medical data
- Keywords
- Non traumatic acute brain injury
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Collection of medical dataOther
A code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected.
| Study group | Role | What they receive |
|---|---|---|
| ICU patients | Patients with Non Traumatic Neuro-Vascular Diseases. Medical data concerning ICU stay will be collected. Receives: Other: Collection of medical data |
What is being measured
The primary outcome is the main question the study is designed to answer.
in ICU stay complications
Hospital acquired infections (epidemiology, risk factors, antibiotic susceptibility of pathogens), Organ failures (incidence, risks factors), Bleeding, Hemorrhage Intra-Cranial Hypertension, Brain Ischemia, Mechanical ventilation weaning, Extubation failure
Measured: Within the first 28 days after ICU admission date
Secondary outcomes (2)
Duration in mechanical ventilation
Measured: in ICU (up to 90 days)
ICU length of stay
Measured: in ICU (up to 90 days)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Mar 2016 (estimated)
- Study startFeb 2013
- Primary completionJan 2050 (estimated)
- Study completionJan 2050 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Non Traumatic Acute Brain InjuryStudies of the same condition, open and under way.
- More trials run by Nantes University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Nantes University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Karim Asehnoune, PhD, MD, Study chair
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02714387
- Sponsor's protocol ID
- RC12_0207 cohorte fiche 1
- Acronym
- ATLANREA
- Status last verified
- Sep 2022
- First submitted
- 16 Mar 2016
- Last updated
- 30 Sep 2022
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prospective Cohort of Patients Hospitalized in West French Intensive Care Units.
- ClinicalTrials.gov ID
- NCT02714387
- Acronym / sponsor ID
- ATLANREA / RC12_0207 cohorte fiche 1
- Conditions
- Non Traumatic Acute Brain Injury
- Keywords
- Non traumatic acute brain injury
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- Nantes University HospitalUniversity, hospital or other
- Study start
- Feb 2013
- Primary completion
- Jan 2050 (estimated)
- Study completion
- Jan 2050 (estimated)
- First posted
- 21 Mar 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed to answer pre-defined scientific projects and to improve management of these conditions.
Detailed description
Anonymous data will be collected by study coordinators in a secured e-database. Cross audit will be performed to check data.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| ICU patients | – | Other: Collection of medical dataPatients with Non Traumatic Neuro-Vascular Diseases. Medical data concerning ICU stay will be collected. |
Who may qualify
- Ages
- 15 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Patients hospitalized in ICU for Non Traumatic Neuro-Vascular Diseases
Key inclusion criteria (1 listed)
- Non Traumatic Neuro-Vascular Diseases
Key exclusion criteria (1 listed)
- Consent withdrawal
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Collection of medical dataA code will be applied to each patient included. Medical data such as demography, Simplified Acute Physiological Score II (SAPS II), Sequential Organ Failure Assessment (SOFA), procedures and complications during ICU stay will be collected. | Other | ICU patients |
Primary outcome
in ICU stay complications
Time frame: Within the first 28 days after ICU admission date
Hospital acquired infections (epidemiology, risk factors, antibiotic susceptibility of pathogens), Organ failures (incidence, risks factors), Bleeding, Hemorrhage Intra-Cranial Hypertension, Brain Ischemia, Mechanical ventilation weaning, Extubation failure
2 secondary outcomes
Duration in mechanical ventilation
Time frame: in ICU (up to 90 days)
ICU length of stay
Time frame: in ICU (up to 90 days)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2022.
Related trials for Non Traumatic Acute Brain Injury
RecruitingObservational study
Non-Invasive Monitoring Methods in Patients With Acute Brain Injury
Brain Injury, Acute
Not yet recruiting
Non-Invasive Triage for Intracranial Hypertension in Prehospital Care
Intracranial Hypertension, Acute Brain Injury
RecruitingObservational study
Hemodynamic ABI Monitor
Traumatic Brain Injury (TBI), Intracerebral Hemorrhage
Not yet recruitingObservational study
Inflammatory and Metabolic Prognostic Assessment in Critically Ill Neurological Patients
Stroke Acute, Encephalitis
Not yet recruitingObservational study
Feasibility of Using an App for Managing Phantom Limb Pain Associated with Combat Injury in Ukraine (PAMELA)
Amputation, Traumatic, Pain, Phantom
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Karim Asehnoune, PhD, MD study chair
6 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Non Traumatic Acute Brain Injury, run by Nantes University Hospital at 6 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 30 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Karim Asehnoune, PhD, MD (02 40 08 73 80 ext. 33, karim.asehnoune@chu-nantes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
in ICU stay complications (time frame: Within the first 28 days after ICU admission date). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2022.